HPV VACCINES
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Mar 23, 2023
app pub date -
Jun 29, 2022
filing date -
Jun 10, 2015
priority date (Note) -
Published
status (Latency Note)
![]() |
A preliminary load of PAIR data current through [] has been loaded. Any more recent PAIR data will be loaded within twenty-four hours. |
PAIR data current through []
A preliminary load of cached data will be loaded soon.
Any more recent PAIR data will be loaded within twenty-four hours.
![]() |
Next PAIR Update Scheduled on [ ] |

Importance

US Family Size
|
Non-US Coverage
|
Abstract
Provided herein are genetically modified arenaviruses suitable as vaccines against neoplastic diseases or cancer. The invention also relates to pharmaceutical compositions and methods for the prevention or treatment of certain infections causing neoplastic diseases or cancer, such as infections with oncogenic viruses. Specifically, provided herein are pharmaceutical compositions, vaccines, and methods of preventing or treating diseases and conditions caused by and associated with infections with Human Papillomavirus (HPV), such as cervical cancer, anogenital cancer, head and neck cancer and skin cancers. Also provided herein are immunotherapies for the treatment of a neoplastic disease, such as a neoplastic disease caused by infection with oncogenic viruses.
First Claim
all claims..Other Claims data not available
Family

- 15 United States
- 10 France
- 8 Japan
- 7 China
- 5 Korea
- 2 Other
Patent Owner(s)
Patent Owner | Address | |
---|---|---|
HOOKIPA BIOTECH GMBH | 1030 WIEN |
International Classification(s)

- 2022 Application Filing Year
- A61K Class
- 20288 Applications Filed
- 3818 Patents Issued To-Date
- 18.82 % Issued To-Date
Inventor(s)
Inventor Name | Address | # of filed Patents | Total Citations |
---|---|---|---|
Aspöck, Andreas | Vienna, AT | 6 | 54 |
# of filed Patents : 6 Total Citations : 54 | |||
Berka, Ursula | Baden, AT | 4 | 22 |
# of filed Patents : 4 Total Citations : 22 | |||
Cohen, Katherine | Vienna, AT | 15 | 82 |
# of filed Patents : 15 Total Citations : 82 | |||
Fuhrmann, Gerhard | Vienna, AT | 8 | 1331 |
# of filed Patents : 8 Total Citations : 1331 | |||
Hinteramskogler, Julia | St. Poelten, AT | 3 | 22 |
# of filed Patents : 3 Total Citations : 22 | |||
Kiefmann, Bettina | Vienna, AT | 6 | 54 |
# of filed Patents : 6 Total Citations : 54 | |||
Lilja, Anders | Vienna, AT | 10 | 300 |
# of filed Patents : 10 Total Citations : 300 | |||
Monath, Thomas | Harvard, US | 9 | 76 |
# of filed Patents : 9 Total Citations : 76 | |||
Orlinger, Klaus | Vienna, AT | 18 | 85 |
# of filed Patents : 18 Total Citations : 85 | |||
Schmidt, Sarah | Vienna, AT | 29 | 60 |
# of filed Patents : 29 Total Citations : 60 | |||
Schwendinger, Michael | Neusiedl am See, AT | 11 | 73 |
# of filed Patents : 11 Total Citations : 73 | |||
Watson, Elizabeth | Vienna, AT | 7 | 57 |
# of filed Patents : 7 Total Citations : 57 |
Cited Art Landscape
- No Cited Art to Display

Patent Citation Ranking
- 1 Citation Count
- A61K Class
- 90.63 % this patent is cited more than
- 2 Age
Forward Cite Landscape
- No Forward Cites to Display

Maintenance Fees
Fee | Large entity fee | small entity fee | micro entity fee | due date |
---|---|---|---|---|
3.5 Year Payment | $1600.00 | $800.00 | $400.00 | Sep 23, 2026 |
7.5 Year Payment | $3600.00 | $1800.00 | $900.00 | Sep 23, 2030 |
11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Sep 23, 2034 |
Fee | Large entity fee | small entity fee | micro entity fee |
---|---|---|---|
Surcharge - 3.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
Surcharge - 7.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
Surcharge - 11.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
Surcharge after expiration - Late payment is unavoidable | $700.00 | $350.00 | $175.00 |
Surcharge after expiration - Late payment is unintentional | $1,640.00 | $820.00 | $410.00 |
Full Text

Legal Events
- No Legal Status data available.

Matter Detail

Renewals Detail
